Wearable Blood Glucose Monitoring Systems Market Size, Share, Growth, And Industry Analysis By Type (Blood Glucose Meter, Blood Glucose Testing Strips, and Wearable Blood Glucose Monitoring Systems) By Application (Hospitals, Clinics, and Others) Regional Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

WEARABLE BLOOD GLUCOSE MONITORING SYSTEMS MARKET OVERVIEW

The global Wearable Blood Glucose Monitoring Systems Market stood at USD 6.211 billion in 2024 and is expected to rise to USD 6.47 billion in 2025, maintaining a strong growth trajectory to reach USD 8.99 billion by 2033, with a CAGR of 4.2% from 2025 to 2033.

A CGM is a compact glucose monitoring and communicating gadget with an implantable or a stick-on (joined to the skin) sensor to distinguish glucose which it truly does continuously, normally at regular intervals. A sensor is either embedded in the skin (by means of a little cannula that is put simply under the skin by your PCP) or connected to the skin adhesively. The sensors should be supplanted each 10 to 90 days, contingent upon the CGM model you use. A transmitter is associated with the sensor to communicate blood glucose readings either to a checking gadget or to your cell phone (contingent upon the CGM model). Most CGM frameworks furnish blood glucose readings alongside extra information, like alerts, for warning of pre-set high and low glucose levels, and that's just the beginning. Finger-sticks are restricted in their capacity to quantify blood glucose levels — which vacillate continually — on a continuous premise. At the point when blood glucose observing is ineffectual, this can mean long haul difficulties of diabetes (like harm to the nerves, circulatory framework, vision issues, and that's just the beginning). Ceaseless glucose checking implies more precise and powerful change of insulin and, in this way, the upkeep of better glucose levels. Today, this is conceivable because of the imaginative wearable tech for diabetes that is accessible. Persistent observing can likewise offer quick continuous security against very high or low blood glucose levels that could bring about risky antagonistic side effects like confusion or obviousness.

The reception of these frameworks is developing at a quicker pace inferable from variables, for example, the rising patient pool living with diabetes, rising mindfulness in regards to glucose checking among patients, and the presentation of novel observing gadgets by vital participants. This, alongside admittance to steady repayment approaches for self-checking blood glucose (SMBG) and nonstop glucose observing frameworks (CGM) in numerous nations, is supposed to additional lift the reception of these gadgets and will hence impel the market development during 2022-2033.

WEARABLE BLOOD GLUCOSE MONITORING SYSTEMS MARKET KEY FINDINGS

• Market Size and Growth: The global wearable blood glucose monitoring systems market was valued at USD 6.211 billion in 2024 and is projected to reach USD 8.99 billion by 2033.

• Key Market Driver: The increasing prevalence of diabetes and supportive government initiatives are primary drivers of market growth.

• Major Market Restraint: High costs and regulatory concerns over unapproved devices hinder market expansion.

• Emerging Trends: Integration of CGMs with mobile technology and their use among non-diabetic populations are notable trends. 

• Regional Leadership: North America holds a significant share of the global blood glucose monitoring system market, accounting for 43.86% in 2023.

• Competitive Landscape: Key players like Roche and LifeScan are focusing on product innovation and expanding their product portfolios to cater to diverse patient needs.

• Market Segmentation: The market is segmented by type into blood glucose meters, testing strips, and wearable monitoring systems, and by application into hospitals, clinics, and others. 

• Recent Development: Abbott Laboratories received FDA approval for new CGMs, including Libre Rio for type 2 diabetes patients not using insulin, and Lingo for non-diabetic individuals aiming to monitor metabolism and aid weight loss.

COVID-19 IMPACT

Desperation to Extend the Accessibility of CGM in Emergency clinics in the midst of Coronavirus Pandemic to Lift Market Development

The Coronavirus pandemic emphatically influenced the blood glucose observing framework market development. A few vital participants detailed development in their diabetes care income because of the flare-up of the pandemic. With the rising gamble of Coronavirus disease among diabetic patients, another spotlight is being put on home use observing gadgets to oversee blood glucose levels at home. Likewise, various clinical associations and market players executed significant stages to satisfy the neglected interest of diabetes patients encountering monetary difficulties during the pandemic. The consequently assisted with normalizing the administration of diabetes across medical services and homecare settings toward the finish of 2021. Besides, because of the pandemic, diabetic patients began utilizing observing frameworks at home, brought about expanding request. Also, significant market players experienced critical expansion in the income from this checking framework in 2021 when contrasted with the earlier year.

LATEST TRENDS

Expanding Infiltration of CGM Gadgets Across Different Fragments to Increase Development

The presentation of cutting-edge innovations, for example, nonstop blood glucose monitoring (CGM) frameworks by market players, have empowered the ongoing observing element for insulin-subordinate patients. Likewise, CGM frameworks offer a few benefits when contrasted with self-observing blood glucose (SMBG) frameworks, for example, being negligibly obtrusive in nature, less excruciating, continuous checking, quick and exact outcomes. Accordingly, such unmistakable advantages these gadgets offer are one of the main considerations moving the inclination of medical services suppliers and patients towards the utilization of CGM.

• Integration of Continuous Glucose Monitoring (CGM) with Mobile Technology: The adoption of CGMs that transmit real-time glucose data to smartphones has seen a significant rise, enhancing patient engagement and glycemic control.

• Expansion of Wearable CGMs in Non-Diabetic Populations: The use of wearable CGMs by health-conscious individuals without diabetes has increased, with devices like Abbott's Lingo targeting this demographic.

Request a Free sample to learn more about this report

WEARABLE BLOOD GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION

By Type Analysis

According to type, the market can be segmented into Blood Glucose Meter, Blood Glucose Testing Strips, Wearable Blood Glucose Monitoring Systems. Blood Glucose Meter being the leading segment of the market by type analysis.

By Application Analysis

Based on application, the market can be divided into Hospitals, Clinics, Others. Hospitals being the leading segment of the market by application analysis.

DRIVING FACTORS

Rising Commonness of Diabetes to Lift the Interest for Blood Glucose Observing Gadgets to Aid the Market Development

A few variables, including quick urbanization and the rising movement towards a stationary way of life, in arising and created nations are essentially answerable for the developing commonness of diabetes. Likewise, a critical increment has been seen in the quantity of patients experiencing type-1 or insulin-subordinate sort 2 diabetes, which has been instrumental in flooding the take-up of these frameworks worldwide. For example, as per the information distributed by Worldwide Diabetes Organization, in 2021, it was assessed that the frequency of type 1 diabetes was 149.5 per 1,000 in youngsters and youths old enough (0-19) years and the worldwide predominance was around 9.8% among the all-out populace. Consequently, the presence of an enormous patient populace experiencing insulin-subordinate diabetes, new item presentation by market players, and ideal repayment are filling the interest and reception of diabetes checking items, like BGMs.

• Rising Prevalence of Diabetes: According to the Centers for Disease Control and Prevention (CDC), as of 2020, approximately 34.2 million people in the U.S. had diabetes, driving the demand for effective glucose monitoring solutions.

• Government Initiatives and Subsidies: Diabetes Australia has advocated for a $200 million investment to subsidize CGMs and insulin pumps, aiming to benefit 400,000 individuals with type 2 diabetes.

New Item Dispatches to Fuel the Development of Painless Glucose Observing Frameworks to Drive the Market Growth

Among types, the obtrusive portion held an overwhelming portion of the worldwide market in 2021. As of now, the higher utilization of SMBG gadgets among diabetic patients is one of the central point’s essentially liable for the strength of the intrusive fragment. Notwithstanding, because of the aggravation related with finger pricking in obtrusive observing gadgets, vital participants are presently zeroing in on presenting a harmless option in the market to work on understanding adherence.

RESTRAINING FACTORS

Lower Determination and Treatment Rate in Arising Nations to Confine the Reception of BGM

The presence of an enormous extent of the undiscovered diabetes populace is one of the central point’s bringing about the lower reception of blood glucose checking framework, particularly in arising nations. The commonness of deferred examination is higher among nations, like China, India, South Africa, Brazil, and others, in correlation with created nations. Additionally, because of the absence of mindfulness among everybody in regards to persistent sicknesses, for example, diabetes mellitus. Additionally, the restricted admittance to cutting edge medical services foundation and the absence of traditional methods by government or confidential associations might ruin development.

• High Cost of CGMs: The expense of CGMs, approximately $100 biweekly, poses affordability challenges for many patients, limiting widespread adoption.

• Regulatory Concerns over Unapproved Devices: The U.S. Food and Drug Administration (FDA) has warned against the use of unauthorized smartwatches and rings claiming to measure blood glucose non-invasively, citing potential health risks due to inaccurate readings.

• Request a Free sample to learn more about this report

•  

WEARABLE BLOOD GLUCOSE MONITORING SYSTEMS MARKET REGIONAL INSIGHTS

Rising Number of Diabetes Patients in The Region Expanding the Market Growth in North America

The North American market for blood glucose checking frameworks recorded at the highest in 2021. The rising number of diabetes patients, developing reception of innovatively progressed clinical gadgets and created per capita clinical costs are a portion of the key factors chiefly responsible for the predominant portion of provincial market.

Asia Pacific is expected to enlist a significant CAGR because of the rising commonness of insulin-subordinate diabetes and a rising number of geriatric populaces around here. Likewise, diabetic patients in nations, for example, Japan and Australia are effectively keen on the normal and opportune observing of their glucose levels. This, alongside the rising accentuation of central participants to foster their immediate presence in non-industrial nations.

Key Industry Players

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Roche (Switzerland): Roche Holding AG is a major player in the blood glucose monitoring market, offering a range of devices that contribute significantly to the industry's growth. 

• LifeScan (U.S.): LifeScan Inc. is a prominent company in the U.S. blood glucose monitoring market, providing innovative solutions for diabetes management.

List of Top Wearable Blood Glucose Monitoring Systems Companies

• Roche (Switzerland)
• LifeScan (U.S.)
• Abbott (U.S.)
• Ascensia (Switzerland)
• ARKRAY (Japan)
• I-SENS (South Korea)
• Omron (Japan)
• B. Braun (Germany)
• 77 Elektronika (Hungary)
• AgaMatrix (U.S.)
• ALL Medicus (U.S.)
• Terumo (Japan)
• Sinocare (China)
• Yicheng (China)
• Yuwell (China)
• Acon (U.S.)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.